Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

MDS Position Paper
Diagnosis of Parkinson’s Disease

March 1, 2023

The Scientific Issues Committee on behalf of the International Parkinson and Movement Disorder Society (MDS) is providing this statement regarding the diagnosis of Parkinson’s disease (PD). This statement is based on the current best available evidence.

The MDS in 2015 published the official MDS Clinical Diagnostic Criteria for Parkinson's disease (MDS-PD Criteria)1. These criteria emerged from the work of the MDS task force for the definition of PD, a group of recognized international experts in PD2.

While the MDS-PD Criteria were designed for use in research, the MDS supports their use as a general guide to diagnosis of PD in clinical settings, and the criteria currently represent the global standard for PD diagnosis. Further, these criteria have been validated against the gold standard of expert clinical diagnosis (neurologists with >10 years' experience in PD diagnosis)3.

The prerequisite to apply the MDS-PD criteria is the diagnosis of parkinsonism, which is based on three clinical motor features (bradykinesia, rest tremor, rigidity). Determination of PD as the cause of parkinsonism relies on three categories of diagnostic features: absolute exclusion criteria, red flags, and supportive criteria. The motor features and most of the diagnostic features are determined by appropriate history taking and skilled neurological examination. Therefore, diagnosis of PD requires sufficient training in neurology. Supportive criteria increase the confidence of the diagnosis, but cannot make the diagnosis on their own. The only laboratory test finding included as a supportive criterion for diagnosis of PD is cardiac sympathetic denervation on MIBG scintigraphy. Normal functional neuroimaging of the presynaptic dopaminergic system excludes a diagnosis of PD. Advances in the field will lead to continuous updates in the diagnostic criteria over time. However, there is no reliable scientific evidence to support the use of blood tests or EEG as diagnostic tests for PD and therefore they are not included in the MDS-PD criteria.

Key Research

Official MDS Clinical Diagnostic Criteria for PD

Currently the global standard for Parkinson's disease diagnosis both for research and clinical uses. 

Review criteria »


Task Force Statement

From the internationally recognized experts authoring group for the criteria. 

Read paper »

Criteria Validation

Conducted by neurologists with more than 10 years' experience in PD diagnosis.

Read paper »


  1. Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 2015;30(12):1591-1601.
  2. Berg D, Postuma RB, Bloem B, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Mov Disord 2014;29(4):454-462.
  3. Postuma RB, Poewe W, Litvan I, et al. Validation of the MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord 2018;33(10):1601-1608.


We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice